2m 2m 2m 2m 2m 2m 2m
NOVAVAX (NVAX)
NASDAQ
$9.93-$0.06 (-0.59%)
Price as of Oct 22, 2026 7:59 PM EDT- $1.8BMarket Cap
- 30.14%1-Year Change
- BiotechnologyIndustry
NOVAVAX (NVAX)
$9.93-$0.06 (-0.59%)
NVAX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $9.99 | ||
Change | -$0.42 (-3.67%) | ||
Open | $10.79 | ||
High | $10.87 | ||
Low | $9.55 | ||
Previous Close | $11.01 | ||
Volume | 12,251,522 | ||
30-Day Average Volume | 8,288,307 | ||
1-Week Change | -12.90% | ||
1-Month Change | 5.76% | ||
1-Year Change | 30.14% | ||
3-Year Change | 71.23% | ||
5-Year Change | -92.07% | ||
Fundamentals | |||
Shares Outstanding | 164.9M | ||
Total Assets | $955.6M | ||
Market Cap | $1.8B | ||
Enterprise Value | $1.9B | ||
Period: QTR TTM FY | |||
Revenue | $18.9M | ||
Net Income | -$53.4M | ||
Free Cash Flow | -$73.4M | ||
EBIT | -$47.1M | ||
EBITDA | -$44.1M | ||
Net Working Capital | $440.5M | ||
EPS | -$0.32 | ||
Enterprise Value/EBITDA | -43 | ||
Enterprise Value/Revenue | 102 | ||
P/B | -10 | ||
P/E | -34 | ||
PEG | 0 | ||
Price/Free Cash Flow | -25 | ||
Price/Operating Cash Flow | -25 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 12/13/2007 | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 05/10/2019 | ||
Earnings & Revenue